Press Release
REPLICor initiates dosing of human patients with its drug
March 2009 — Under its IRB-approved protocol, Replicor initiated treatment of patients enrolled in its phase I / II trial with its drug.
March 2009 — Under its IRB-approved protocol, Replicor initiated treatment of patients enrolled in its phase I / II trial with its drug.